Concepedia

Samuel Yamshon

SY

Statistics

Publications

8

Citations

280

H-Index

8

Active since

2020

Affiliations

Cornell University(Current)

Weill Cornell Medicine

Presbyterian Hospital

University of Pennsylvania

Roswell Park Comprehensive Cancer Center

Samuel Yamshon is an author at Cornell University specializing in immunotherapy, oncology, and medicine.

Publications per year

2020–2025

8

Publications

8

COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study

Gagandeep Brar, Laura C. Pinheiro, Michael Shusterman et al. · Journal of Clinical Oncology · 2020 · 135 citations · Full text

Medicine, Infectious Diseases, Oncology +10

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Yusuke Isshiki, Xi Chen, Matt Teater et al. · Cancer Cell · 2024 · 59 citations · Full text

Life Sciences, Immunology, Oncology +14

Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Mateo Mejía Saldarriaga, Darren Pan, Caitlin Unkenholz et al. · Blood Advances · 2024 · 33 citations · Full text

Medicine, Hematology, Immunology +15

Long COVID in Cancer

Olivia Fankuchen, Jennifer D. Lau, Mangala Rajan et al. · American Journal of Clinical Oncology · 2023 · 12 citations · Full text

Medicine, Infectious Diseases, Oncology +12

Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel

Jason T. Romancik, Subir Goyal, James N. Gerson et al. · Blood · 2021 · 11 citations

Medicine, Hematology, Oncology +12

1–5 of 8